Anthem Biosciences Limited
WhiteOak Capital Mutual Fund bought 1,00,458 shares of Anthem Biosciences for ₹7.48 Cr at ₹744.80 apiece in a block deal.
A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.
Founded by Prashant Khemka, former CIO of Goldman Sachs Asset Management India. Manages over Rs 20,000 crore with a concentrated bottom-up approach rooted in fundamental quality research. WhiteOak's edge is the proprietary SQGLP (Scalability, Quality, Growth, Longevity, Price) framework applied with global research standards to Indian equities.